![Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc](https://www.jewd.eg.net/articles/2021/18/1/images/JEgyptWomensDermatolSoc_2021_18_1_67_308298_t6.jpg)
Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc
![Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3880543/MediaObjects/41379_2002_Article_BF3880543_Fig3_HTML.jpg)
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
LYMPHATIC AND SMALL BLOOD VESSEL DENSITY IN THE TUMOR AND PERITUMORAL TISSUE IN INVASIVE BREAST CARCINOMA OF NO SPECIAL TYPE
![Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2F1471-2407-8-64/MediaObjects/12885_2007_Article_1002_Fig2_HTML.jpg)
Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis | BMC Cancer | Full Text
![D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients | Modern Pathology D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.2010.199/MediaObjects/41379_2011_Article_BFmodpathol2010199_Fig4_HTML.jpg)
D2-40/p63 defined lymph vessel invasion has additional prognostic value in highly proliferating operable node negative breast cancer patients | Modern Pathology
![D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962212003465-gr2.jpg)
D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect
![D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0190962212003465-gr1.jpg)
D2-40 immunohistochemical overexpression in cutaneous squamous cell carcinomas: A marker of metastatic risk - ScienceDirect
![Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fmodpathol.3880543/MediaObjects/41379_2002_Article_BF3880543_Fig2_HTML.jpg)
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
![Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fmodpathol.3880543/MediaObjects/41379_2002_Article_BF3880543_Fig1_HTML.jpg)
Monoclonal Antibody D2-40, a New Marker of Lymphatic Endothelium, Reacts with Kaposi's Sarcoma and a Subset of Angiosarcomas | Modern Pathology
![Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc](https://www.jewd.eg.net/articles/2021/18/1/images/JEgyptWomensDermatolSoc_2021_18_1_67_308298_f1.jpg)
Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc
![Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc Sensitivity and specificity of D2-40 in differentiating Kaposi sarcoma from its mimickers Genedy RM, Hamza AM, Abdel Latef AA, El-Beity AA - J Egypt Womens Dermatol Soc](https://www.jewd.eg.net/articles/2021/18/1/images/JEgyptWomensDermatolSoc_2021_18_1_67_308298_f2.jpg)